FDA panel to review Lifecore's Intergel application:
This article was originally published in Clinica
Executive Summary
An advisory panel to the US FDA is to review on November 16 Lifecore Biomedical's premarket approval (PMA) application for its Intergel solution for preventing post-operative adhesion formation after gynaecological laparotomy procedures. The Chaska, Minnesota-based company said it plans to file a PMA supplement to use the product in gynaecological laparoscopy procedures at a later date.